Literature DB >> 16519572

Basal cell-signet-ring squamous cell carcinoma of the eyelid.

Alan D Proia1, M Angelica Selim, Jason C Reutter, John J Michon.   

Abstract

A 93-year-old woman developed a mass on her right lower eyelid that was present for more than 6 months but underwent rapid expansion during several weeks prior to her ophthalmological evaluation. Examination revealed an approximately 1.8 cm in diameter, fleshy, fungating growth involving more than 60% of the right lower eyelid. Excisional biopsy disclosed a neoplasm arising from the epidermis composed of adjoining basal cell and signet-ring squamous cell carcinoma, without a transition zone. The cells comprising the basal and squamous cell carcinomas were distinct immunophenotypically, with only the basal cell carcinoma reacting with Ber-EP4 and CAM 5.2 antibodies. To our knowledge, this case represents the first example of a collision tumor composed of basal cell and signet-ring squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16519572     DOI: 10.5858/2006-130-393-BCSCCO

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

Review 1.  Imaging of adult ocular and orbital pathology--a pictorial review.

Authors:  Reuben Grech; Kurt Spiteri Cornish; Patrick Leo Galvin; Stephan Grech; Seamus Looby; Alan O'Hare; Adrian Mizzi; John Thornton; Paul Brennan
Journal:  J Radiol Case Rep       Date:  2014-02-01

2.  A benign or malignant eyelid lump--can you tell? An unusual collision tumour highlighting the difficulty differentiating a hidrocystoma from a basal cell carcinoma.

Authors:  Anuradha Jayaprakasam; Cornelius Rene
Journal:  BMJ Case Rep       Date:  2012-06-28

Review 3.  Intraocular collision tumour: case report and literature review.

Authors:  Sarah E Coupland; Andrew Dodson; Hongxiang Liu; Ming-Qing Du; Martina Angi; Bertil E Damato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-12       Impact factor: 3.117

4.  [Collision tumor].

Authors:  J Braunstein; F G Holz; K U Löffler
Journal:  Ophthalmologe       Date:  2018-01       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.